Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy.
HIV persists during antiretroviral therapy (ART) as integrated proviruses in cells descended from a small fraction of the CD4+ T cells infected prior to the initiation of ART. To better understand what controls HIV persistence and the distribution of integration sites (IS), we compared about 15,000...
Main Authors: | John M Coffin, Michael J Bale, Daria Wells, Shuang Guo, Brian Luke, Jennifer M Zerbato, Michele D Sobolewski, Twan Sia, Wei Shao, Xiaolin Wu, Frank Maldarelli, Mary F Kearney, John W Mellors, Stephen H Hughes |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-04-01
|
Series: | PLoS Pathogens |
Online Access: | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009141&type=printable |
Similar Items
-
An analytical pipeline for identifying and mapping the integration sites of HIV and other retroviruses
by: Daria W. Wells, et al.
Published: (2020-03-01) -
The largest HIV-1-infected T cell clones in children on long-term combination antiretroviral therapy contain solo LTRs
by: Johannes C. Botha, et al.
Published: (2023-08-01) -
Tracking HIV-1-Infected Cell Clones Using Integration Site-Specific qPCR
by: Leah D. Brandt, et al.
Published: (2021-06-01) -
HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer
by: Lulu Yu, et al.
Published: (2024-05-01) -
HIV infected CD4+ T cell clones are more stable than uninfected clones during long-term antiretroviral therapy.
by: Shuang Guo, et al.
Published: (2022-08-01)